Soham Shukla

5PUBLICATIONS
20CO-AUTHORS
Toxicology (incl. clinical toxicology)Semi- and unsupervised learningCarbon capture engineering (excl. sequestration)PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 28, 2023
Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UK.

Robyn Kendall, Alan A Martin, Dhvani Shah

|Nov 01, 2022
Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial.

David M G Halpin, Robyn Kendall, Soham Shukla

|Sep 14, 2022
Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain.

Victoria Neches García, Laura Amanda Vallejo-Aparicio, Afisi S Ismaila

|Dec 17, 2021
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model.

Soham Shukla, Dhvani Shah, Alan Martin

|Mar 09, 2021
Impact of body mass index on survival and serious adverse events in advanced non-small cell lung cancer treated with bevacizumab: a meta-analysis of randomized clinical trials.

Soham Shukla, Zachary Babcock, Laura Pizzi

Pageof 1

Frequent Collaborators

4 joint publications

Afisi S Ismaila

3 joint publications

Alan Martin

3 joint publications

Robyn Kendall

2 joint publications

Paul W Jones